Increasing of circulating PRL can trigger the development of MetS in diabetic rats by reducing hypothalamic dopaminergic neurotransmission and subsequent abnormal lipogenic responsiveness to the effect of peripheral insulin. The gene discussed is PRL; the disease is metabolic syndrome.